PARP14 promotes the proliferation and gemcitabine chemoresistance of pancreatic cancer cells through activation of NF‐κB pathway
Authors:
- 10 April 2019
- journal article
- research article
- Published by Wiley in Molecular Carcinogenesis
- Vol. 58 (7) , 1291-1302
Abstract
Pancreatic cancer (PC) is the most fatal gastrointestinal malignancy in the world, with a 5‐year relative survival of only 8%. Poly(ADP‐ribose) polymerase (PARP)14, a member of the macro‐PARP subfamily proteins, has been reported to participate in various biologic and pathologic processes in multiple cancers. The roles and underlying molecular mechanisms of PARP14 in PC carcinogenesis, however, remain to be elucidated. In this study, we for the first time discovered that PARP14 was highly expressed in human primary PC specimens and significantly correlated with poor patient prognosis. Using loss‐of‐function studies in vitro and in vivo, we showed that the knockdown of PARP14 led to enhanced apoptosis, repressed proliferation, and gemcitabine (GEM) resistance of PC cells. Further investigations revealed that PARP14 was significantly overexpressed in GEM‐resistant PC cells (SW1990/GZ). And silencing of PARP14 significantly reversed the GEM resistance of SW1990/GZ cells. To the mechanism, PARP14 could stimulate PC progression by the activation of nuclear factor‐κB (NF‐κB) signaling pathway. And inhibition of NF‐κB signal could significantly reverse PARP14–overexpression triggered PC carcinogenesis. In conclusion, PARP14 could promote PC cell proliferation, antiapoptosis, and GEM resistance via NF‐κB signaling pathway, highlighting its potential role as a therapeutic target for PC.Keywords
Funding Information
- Natural Science Foundation of Jiangsu Province (BK20161590)
This publication has 32 references indexed in Scilit:
- Poly(ADP-ribose) polymerase family member 14 (PARP14) is a novel effector of the JNK2-dependent pro-survival signal in multiple myelomaOncogene, 2012
- KrasG12D-Induced IKK2/β/NF-κB Activation by IL-1α and p62 Feedforward Loops Is Required for Development of Pancreatic Ductal AdenocarcinomaCancer Cell, 2012
- Glycolytic rate and lymphomagenesis depend on PARP14, an ADP ribosyltransferase of the B aggressive lymphoma (BAL) familyProceedings of the National Academy of Sciences, 2011
- NF-κB mediates radio-sensitization by the PARP-1 inhibitor, AG-014699Oncogene, 2011
- PARP-14 Functions as a Transcriptional Switch for Stat6-dependent Gene ActivationJournal of Biological Chemistry, 2011
- Combining affinity purification by ADP-ribose-binding macro domains with mass spectrometry to define the mammalian ADP-ribosyl proteomeProceedings of the National Academy of Sciences, 2009
- PARP-14, a member of the B aggressive lymphoma family, transduces survival signals in primary B cellsBlood, 2009
- Substrate-Assisted Catalysis by PARP10 Limits Its Activity to Mono-ADP-RibosylationMolecular Cell, 2008
- NF-κB in carcinoma therapy and preventionExpert Opinion on Therapeutic Targets, 2008
- The PARP superfamilyBioEssays, 2004